Literature DB >> 29284222

Primary and secondary prevention of breast cancer.

Agnieszka Kolak1, Marzena Kamińska2, Katarzyna Sygit3, Agnieszka Budny4, Dariusz Surdyka4, Bożena Kukiełka-Budny2, Franciszek Burdan5.   

Abstract

INTRODUCTION: Breast cancer is the most common cancer among women and is the second cancer frequently occurring worldwide of newly-diagnosed cancers. There is much evidence showing the influence of life style and environmental factors on the development of mammary gland cancer (high-fat diet, alcohol consumption, lack of physical exercise), the elimination of which (primary prevention) may contribute to a decrease in morbidity and mortality. Secondary prevention, comprising diagnostic tests (e.g. mammography, ultrasonography, magnetic resonance imaging, breast self-examination, as well as modern and more precise imaging methods) help the early detection of tumours or lesions predisposing to tumours.
OBJECTIVE: The aim of this study paper is to review current knowledge and reports regarding primary and secondary prevention of breast cancer. STATE OF KNOWLEDGE: It is estimated that nearly 70% of malign tumours are caused by environmental factors, whereas in breast cancer this percentage reaches 90-95%. There are national programmes established in many countries to fight cancer, where both types of prevention are stressed as serving to decrease morbidity and mortality due to cancers.
CONCLUSIONS: Cancer prevention is currently playing a key role in the fight against the disease. Behaviour modification, as well as greater awareness among women regarding breast cancer, may significantly contribute towards reducing the incidence of this cancer. Another important aspect is the number of women undergoing diagnostic tests, which still remains at an unsatisfactory level.

Entities:  

Keywords:  breast cancer; life style; mammography; modern diagnostics methods; primary and secondary prevention; risk factors

Mesh:

Year:  2017        PMID: 29284222     DOI: 10.26444/aaem/75943

Source DB:  PubMed          Journal:  Ann Agric Environ Med        ISSN: 1232-1966            Impact factor:   1.447


  47 in total

1.  Value of ultrasound elastography combined with contrast-enhanced ultrasound and micro-flow imaging in differential diagnosis of benign and malignant breast lesions.

Authors:  Zuopeng Ding; Weiyong Liu; Nianan He; Xiaopeng Ma; Lili Fu; Lei Ye
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Sentinel lymph node metastasis diagnosis using ultrasound plus magnetic resonance lymphangiography in breast cancer.

Authors:  Yishan He; Oufei Liu; Jing Su; Qing Hong; Mengquan Li
Journal:  Gland Surg       Date:  2022-06

3.  The neoadjuvant chemotherapy responses and survival rates of patients with different molecular subtypes of breast cancer.

Authors:  Hui Zhang; Xiaoyu Zhang; Lijun Jin; Zunyi Wang
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

4.  Epigenetic regulation of LINC01270 in breast cancer progression by mediating LAMA2 promoter methylation and MAPK signaling pathway.

Authors:  Shaoying Li; Jiamei Hu; Guisen Li; Huifen Mai; Yinfei Gao; Bichan Liang; Huacong Wu; Jianling Guo; Yuan Duan
Journal:  Cell Biol Toxicol       Date:  2022-10-14       Impact factor: 6.819

5.  Breast Cancer Perception Scale: Psychometric Development Study.

Authors:  Seçil Taylan; İlknur Özkan; Derya Adıbelli
Journal:  Eur J Breast Health       Date:  2021-03-31

6.  The expression of programmed death-ligand 1 in patients with invasive breast cancer.

Authors:  Yi Meng; Hongyan Wu; Yongzhong Yao; Rong Li
Journal:  Gland Surg       Date:  2020-12

7.  dNLR and TILS can be used as indicators for prognosis and efficacy evaluation of neo-adjuvant chemotherapy in breast cancer.

Authors:  Xiaorui Wang; Weipeng Zhao; Lihong He; Shuling Wang; Weidong Li; Jing Wang; Zhongsheng Tong
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

8.  MST1 inhibits the progression of breast cancer by regulating the Hippo signaling pathway and may serve as a prognostic biomarker.

Authors:  Xiang Jin; Lihua Zhu; Sheng Xiao; Zhuhong Cui; Jing Tang; Jiangyong Yu; Mingjun Xie
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

9.  Bioinformatics analysis to screen key prognostic genes in the breast cancer tumor microenvironment.

Authors:  Qian Ye; Xiaowen Han; Zhengsheng Wu
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

10.  Long non-coding RNA NORAD inhibition upregulates microRNA-323a-3p to suppress tumorigenesis and development of breast cancer through the PUM1/eIF2 axis.

Authors:  Pengfei Shi; Jiaming Zhang; Xun Li; Wenhuan Li; Hai Li; Peng Fu
Journal:  Cell Cycle       Date:  2021-06-14       Impact factor: 5.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.